CoreAge Rx vs FitRx
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and FitRx head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
FitRx
FDA warning letter, February 2026 — issued to FitRX, LLC dba FitRx. See the FDA's warning letter database.
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 72 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make FitRx a bad call — it's best for readers who can obtain a written plan quote distinguishing insurance coordination, membership and medication fulfillment. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | FitRx |
|---|---|---|
| Brief Score | 94/100 (A) | 72/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Confirm the quarterly payment $151/month equivalent requires a quarterly purchase; full upfront charge unconfirmed. Ordinary membership excludes medication; selected Doctor + GLP-1 bundles include it. Full price detailsCompounded semaglutide offered; complete current selected-plan and upfront quote unknown; advertised equivalent from $151/month requires quarterly purchase; earlier listing: From $151/mo (quarterly plan, compounded) |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Confirm dose and plan total Advertised from $216/month; confirm dose, supply and full payment. Ordinary membership and Doctor + GLP-1 bundles include different costs. Full price detailsCompounded tirzepatide offered; complete current selected-dose and plan quote unknown; advertised starting figure $216/month; earlier listing: Not disclosed |
| Coverage | US only; restrictions by state, confirmed at intake | Selected treatment availability depends on patient location, clinician licensing and pharmacy eligibility; confirm your state |
| Brand-name access | Not confirmed | Names Wegovy, Ozempic, Zepbound and Mounjaro; the medication and coverage depend on the selected program. |
| Oral / sublingual | Injection only | Unconfirmed |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
FitRx: Advertised semaglutide $151/month equivalent requires a quarterly purchase; FAQ tirzepatide starts at $216/month. Confirm dose, upfront total and selected Doctor+GLP-1 bundle.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.